Evaluation of Lupus Cases Related to TNF Inhibitors in Children
An Adverse Reaction of Anti-TNF Therapy
Abstract views: 104
Keywords:Child, infliximab, systemic lupus erythematosus
Systemic lupus erythematosus (SLE) due to anti-tumor necrosis factor (TNF) agents is a rare entity. We reported three cases who developed lupus-like syndrome while receiving infliximab therapy for various reasons. All cases demonstrated clinical and laboratory findings of SLE. And all of them needed treatment. We would like to emphasize that the risk of anti-TNF-alpha-induced lupus should be kept in mind in patients receiving anti-TNF therapy for any reason.
How to Cite
Copyright (c) 2023 The Journal of Pediatric Academy
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.